Description

Bisolvon Syrup (125ml)

The bromhexine-based syrup is indicated to favor the fluidification and elimination of phlegm.

INDICATIONS

Treatment of secretion disorders in acute and chronic respiratory diseases.

CONTRADICTIONS

Hypersensitivity to the active substance or to any of the excipients; children under the age of 2; in case of hereditary conditions that may be incompatible with one of the excipients; there are no absolute contraindications, but in patients with gastroduodenal ulcer, it is recommended to use it after medical consultation; contraindicated during breastfeeding.

POSOLOGY

Adults: 5 – 10 ml 3 times a day. In adults, at the start of treatment, it may be necessary to increase the total daily dose up to 48 mg divided in three times.

Children over 2 years of age: 2.5 – 5 ml 3 times a day. It is recommended to take the drug after meals.

The syrup can be administered to diabetics and children over 2 years, it does not contain fructose or sucrose. Do not exceed the recommended dose. To measure the appropriate dose, use the measuring cup included in the package

WARNINGS

Treatment with the medicine leads to an increase in bronchial secretion (this favors expectoration). Do not use for prolonged treatments. When treating acute respiratory conditions, consult your doctor if symptoms do not improve or worsen over the course of therapy. In very few cases, severe skin lesions such as Stevens Johnson syndrome and toxic epidermal necrolysis (NET) have been observed simultaneously with the administration of expectorants such as bromhexine. Most of these could be explained by the severity of underlying diseases or other medications taken at the same time. Also in the early stages of Stevens Johnson syndrome or toxic epidermal necrolysis (NET), patients may initially experience non-specific flu-like symptoms such as fever, chills, rhinitis, cough and sore throat. Due to these misleading symptoms it is possible that symptomatic treatment with cough and cold therapy may be undertaken. Therefore, if new lesions of the skin or mucous membranes occur, stop the treatment with bromhexine as a precaution during subsequent investigations. Mucolytics can induce bronchial obstruction in children under 2 years of age. In fact, the drainage capacity of the bronchial mucus is limited in this age group, due to the physiological characteristics of the respiratory tract. They should therefore not be used in children under 2 years of age. The medicine contains liquid maltitol. This medicine may have a mild laxative effect.